Scientific progress is breaking barriers across multiple disciplines, reshaping what we thought was achievable. Recent breakthroughs include diverting asteroid trajectories to prevent potential destruction, employing advanced mapping techniques inspired by astronomy to enhance cancer immunotherapy, and pioneering neurotechnology that offers unprecedented control over the human vestibular system. Collaborative efforts fueled by artificial intelligence tools are driving these innovations, all united by a common goal: improving the human condition. Highlights include NASA's DART mission's success in asteroid redirection, the AstroPath system that refines tumor immune mapping, and Orbit's neurotechnology devices aimed at enhancing cognition and sleep quality through vestibular system manipulation.

Anthropic introduces Claude for Healthcare, a new AI solution aimed at enhancing services for clinicians, insurers, and patients, marking its expansion into the healthcare sector shortly after OpenAI rolled out a comparable product.

An investigation by The Guardian revealed that Google's AI-generated health summaries were providing inaccurate information regarding blood tests, putting users' health at risk. In response, Google has removed some of these AI Overviews from its search features. The company maintains that its AI tools are designed to offer helpful and reliable snapshots of information, but is taking steps to address the reported issues.

NASA is taking the unprecedented step of shortening a mission aboard the International Space Station due to a medical situation involving an astronaut. The U.S.-Japanese-Russian crew of four will return to Earth sooner than originally planned. The agency canceled a scheduled spacewalk to address the astronaut’s health, though the individual’s identity and condition remain confidential. According to Dr. James Polk, NASA's chief health officer, this marks the first medical evacuation from the station, despite prior onboard treatments for minor issues. The crew, who arrived via SpaceX in August, included NASA astronauts Zena Cardman and Mike Fincke, Japan’s Kimiya Yui, and Russia’s Oleg Platonov. NASA emphasizes the return is precautionary and is committed to crew safety. Meanwhile, other astronauts continue their mission aboard the station, with SpaceX slated to assist in retiring the station safely by 2030 or 2031.

I've often observed that most products on the market aren't groundbreaking innovations but rather reflections of our everyday behaviors, habits, and concerns. Design tends to follow these patterns. Consider this: many people already consult ChatGPT regularly for health-related advice—not just once in a while, but as a trusted second opinion, a confidential sounding board, or even a source of emotional support without fear of judgment. Once these behaviors become consistent, companies shift from merely watching to actively developing solutions tailored to these needs.

Amgen has acquired Dark Blue Therapeutics, a UK-based biotech firm, in a deal worth $840 million. This purchase aims to accelerate Amgen's advancements in developing innovative cancer therapies.

While AI often makes headlines as a job disruptor, behavioral health is witnessing a different narrative. This field values human connection above all, focusing on trust and healing rather than mere efficiency. In 2026, AI will enhance behavioral health by empowering clinicians, not replacing them. By alleviating administrative burdens like documentation and scheduling, AI will enable clinicians to focus more deeply on patient care, revitalizing their original passion for the profession.

We can anticipate several key advances: therapy will become more personalized as AI highlights emotional and behavioral patterns in real time, administrative tasks will be streamlined to give providers more time with patients, and fostering trust in AI's role will be central to care. Attention to staff well-being will improve through AI tools that monitor workload and burnout signs, supporting a healthier workforce. Additionally, AI will help clinics demonstrate measurable outcomes, unlocking new resources and supporting value-based care models.

Ultimately, the integration of AI in behavioral health aims not to change the core of good care, but to increase access and sustainability by reducing clinician burnout and improving care quality. Organizations embracing AI as vital infrastructure will lead in scaling compassionate, effective behavioral health services in the years ahead.

OpenAI is set to launch ChatGPT Health, a specialized feature that will provide a dedicated platform for health-related discussions with ChatGPT, expected to be available in the coming weeks.

OpenAI has introduced ChatGPT Health, a new feature that connects users' medical records and wellness apps with its AI chatbot to offer personalized health advice. This dedicated health section within ChatGPT allows users to gather data from fitness and wellness apps such as Apple Health, Peloton, MyFitnessPal, and Function Health. Through a partnership with b.well, users can also access their electronic medical records securely, with authentication often facilitated via their provider's portal, including systems like MyChart. The product has been developed over two years with input from more than 260 physicians worldwide and incorporates a specialized health AI model evaluated using a tool called HealthBench. Privacy and data encryption are central, with health data excluded from OpenAI's other model training. While not FDA-approved and not a substitute for professional medical diagnosis, ChatGPT Health aims to help users prepare for medical appointments, understand tests, get exercise and diet tips, and navigate insurance. Currently in limited release, OpenAI plans to broaden access soon.

Editor's note: This article is part of Crunchbase's 2026 forecast series. The IPO market is showing a renewed vibrancy after a period of dormancy, driven by better public market conditions, stable interest rates, and growing investor enthusiasm for growth companies. Leveraging Crunchbase’s predictive analytics, which consider funding rounds, growth indicators, investor diversity, and market timing, we've identified 15 companies across sectors like AI, enterprise software, fintech, space, defense, healthcare, and consumer tech that are poised to potentially go public in 2026 if favorable market momentum continues. Highlights include AI infrastructure unicorn Crusoe Energy Systems, AI and data giants like Databricks and Cohere, design platform Canva, quantum computing firm Quantinuum, space tech leaders K2 Space and SpaceX, defense innovator Anduril, healthcare data platform Innovaccer, cybersecurity firms Huntress and Ledger, and fintech disruptors such as Plaid, Revolut, and Monzo. Each company demonstrates strong revenue growth, sizable funding, strategic investor support, and readiness signals for public market entry. While IPO predictions are not guarantees, these companies show many of the typical markers leading up to a public listing, backed by Crunchbase’s detailed methodology.